Bylined Articles and Infographics

Bylined Articles and Features

PM360 – Patient Advocates Assume a Large Role as Orphan Drug Development Expands
by Juliet M. Moritz, MPH, Executive Director, Patient Engagement and Strategic Development

Life Sciences IP Review – Medical devices new rules: the clock is ticking [Subscription needed]
by Jo Emmett, Vice President, Medical Device

PharmaLive – Incentives, Opportunities Abound as Orphan Drug Demand Grows
by Lisa N. Pitt, PharmD, MSJ, Vice President, Global Regulatory Affairs, and
Angi Robinson, Executive Director, Strategic Development Department, Rare Disease & Pediatrics

Life Sciences IP Review – Running an Efficient Clinical Drug Trial [Subscription needed]
by Charlie Nicholson, Chief Financial Officer

Drug Development & Discovery – The Opportunity in Sharing Risk: A Productive Trend in Clinical Trials
by Sean Russell, Chief Commercial Officer

CenterWatch Weekly – 3 Questions with Juliet Moritz
by Juliet M. Moritz, MPH, Executive Director, Strategic Development Department, Rare Diseases




Orphan Drugs & Rare Disease

Phone Us Now
Email Us Now